Frequent inactivation of A20 in B-cell lymphomas

Motohiro Kato, Masashi Sanada, Itaru Kato, +26

Nature

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology +4

Identification of novel candidate loci for anorexia nervosa at 1q41 and 11q22 in Japanese by a genome-wide association analysis with microsatellite markers

Kazuhiko Nakabayashi, Gen Komaki, Atsushi Tajima, +8

Journal of Human Genetics

Genome-wide Association StudyGenotype-phenotype AssociationEating DisordersGeneticsNovel Candidate Loci +6

Expression pattern of <scp>PD</scp>‐L1 and <scp>PD</scp>‐L2 in classical Hodgkin lymphoma, primary mediastinal large B‐cell lymphoma, and gray zone lymphoma

Yosuke Tanaka, Akiko Miyagi Maeshima, Junko Nomoto, +6

European Journal Of Haematology

Histological and immunophenotypic changes in 59 cases of B‐cell non‐Hodgkin's lymphoma after rituximab therapy

Akiko Miyagi Maeshima, Hirokazu Taniguchi, Junko Nomoto, +6

Cancer Science

Diffuse large B‐cell lymphoma after transformation from low‐grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses

Akiko Miyagi Maeshima, Mutsuko Omatsu, Junko Nomoto, +6

Cancer Science

ImmunologyPathologyImmunophenotypingImmunotherapyTumor Biology +17

The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma

M Mori, Yukio Kobayashi, Akiko Miyagi Maeshima, +12

Annals of Oncology

Lymphoid NeoplasiaSurgical PathologyImmunologyPathologyIndolent Course +2

Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma

Junko Nomoto, Nobuhiro Hiramoto, Motohiro Kato, +14

BMC Cancer

Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL

Dai Maruyama, Takashi Watanabe, Akiko Miyagi Maeshima, +9

International Journal of Hematology

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunology +7

A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas

Midori Ando, Yasuharu Sato, Katsuyoshi Takata, +7

PLoS ONE

ImmunodeficienciesImmunologyImmune RegulationPathologyImmune System +15

Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy

Akiko Miyagi Maeshima, Hirokazu Taniguchi, Junko Nomoto, +9

Human Pathology

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology +10